Impact of Extracapsular Extension on Survival Outcomes in NSCLC Patients

Overview

This study evaluates the prognostic significance of extracapsular extension (ECE) in non-small cell lung cancer (NSCLC) patients following neoadjuvant chemoimmunotherapy (NCIT).

Background

Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality, with neoadjuvant chemoimmunotherapy (NCIT) improving pathologic response rates. Despite these advancements, disease recurrence remains common, and extracapsular extension (ECE) is recognized as a hallmark of aggressive tumor behavior.

Data Highlights

Key Findings

• ECE was identified as an independent prognostic factor for disease-free survival (DFS) with a hazard ratio of 2.37.
• Patients with ECE-positive status had significantly worse DFS compared to ECE-negative patients.
• Integrating ECE status with major pathologic response (MPR) improved predictive accuracy for 2-year DFS.
• Lymphovascular invasion (LVI) was found to be an independent predictor of overall survival (OS) with a hazard ratio of 3.99.
• The study included 104 patients with pathologically confirmed lymph node metastasis who underwent surgery after NCIT.

Clinical Implications

The findings indicate that ECE status is associated with disease-free survival (DFS) outcomes in NSCLC patients following NCIT.

Conclusion

Extracapsular extension is a significant prognostic factor for disease-free survival in NSCLC patients after neoadjuvant treatment.

Related Resources & Content

1. Author(s)/Org, Source, Year -- Title
2. The ASCO Post, 2011 -- Incremental Advances Demonstrated in Management of Locoregional Lung Cancer
3. The ASCO Post, 2025 -- Overall Survival Benefit Shown for Neoadjuvant Nivolumab Plus Chemotherapy in Non–Small Cell Lung Cancer
4. NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 7.2025 - PubMed
5. The ASCO Post — Neoadjuvant Immunotherapy May Benefit Patients With Early-Stage NSCLC
6. NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 7.2025 - PubMed
7. Review
8. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the Classification of Residual Tumor After Resection for the Forthcoming (Ninth) Edition of the TNM Classification of Lung Cancer - ScienceDirect